Ginsenoside Rg1 Improves Inflammation and Autophagy of the Pancreas and Spleen in Streptozotocin-Induced Type 1 Diabetic Mice
Background. Ginsenoside Rg1 (Rg1) is one of the key bioactive components of the precious Traditional Chinese Medicine that has been used to treat diabetes in China. Ginsenosides have been reported to protect diabetics from tissue damage, inflammation, and insulin resistance. Type 1 diabetes (T1D) is...
Saved in:
| Main Authors: | Yi Zong, Weihua Yu, Hanghang Hong, Zhiqiang Zhu, Wenbo Xiao, Kewu Wang, Guoqiang Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2023/3595992 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ginsenoside Rg1: A bioactive therapeutic agent for diverse liver diseases
by: Mingyu Wu, et al.
Published: (2025-02-01) -
WCN24-2174 The role of Ginsenoside Rg3 in Ischemia Reperfusion renal Injury Mice via AMPK and autophagy
by: Kyungho Park, et al.
Published: (2024-04-01) -
Ginsenoside Rg1 as a Potential Regulator of Hematopoietic Stem/Progenitor Cells
by: Fang He, et al.
Published: (2021-01-01) -
Ginsenoside Rg1 Alleviates Blood–Milk Barrier Disruption in Subclinical Bovine Mastitis by Regulating Oxidative Stress-Induced Excessive Autophagy
by: Shanshan Yang, et al.
Published: (2024-11-01) -
Ginsenoside Rg1 treatment alleviates renal fibrosis by inhibiting the NOX4–MAPK pathway in T2DM mice
by: Pengmin Ji, et al.
Published: (2023-12-01)